Palvella Therapeutics, Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | |
| 3.8% | – | -56.6% | – | – | – | – | – | – | – | – | – | – | |
| 96.2% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 49.2% | 342.9% | 1,856.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | 1,462.3% | – | – | – | – | – | – | – | – | – | – | |
| 80.4% | 522.0% | 3,318.9% | – | – | – | – | – | – | – | – | – | – | |
| 15.8% | -422.0% | -3,318.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | 1,518.9% | – | – | – | – | – | – | – | – | – | – | |
| -55.1% | -352.9% | -4,784.9% | – | – | – | – | – | – | – | – | – | – | |
| -55.1% | -352.9% | -4,784.9% | – | – | – | – | – | – | – | – | – | – | |
| -51.3% | -352.9% | -3,266.0% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.